Title: Biblio RTF Export
Author: Biblio 7.x

Rubinow KB, Wall VZ, Nelson J, Mar D, Bomsztyk K, Askari B, Lai MA, Smith KD, Han MSook, Vivekanandan-Giri A, et al. Acyl-CoA synthetase 1 is induced by Gram-negative bacteria and lipopolysaccharide and is required for phospholipid turnover in stimulated macrophages. J Biol Chem. 2013  ;288(14):9957-70.

Fang FC. Antibiotic and ROS linkage questioned. Nat Biotechnol. 2013  ;31(5):415-6.

Wollish AC, Ferris MT, Blevins LK, Loo Y-M, Gale M, Heise MT. An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo. Virology. 2013  ;435(2):269-80.

Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, et al. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 2013  ;9(1):e1003118.

Ermler ME, Yerukhim E, Schriewer J, Schattgen S, Traylor Z, Wespiser AR, Caffrey DR, Chen ZJ, King CH, Gale M, et al. RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge. J Virol. 2013  ;87(9):4846-60.

Suthar MS, Brassil MM, Blahnik G, McMillan A, Ramos HJ, Proll SC, Belisle SE, Katze MG, Gale M. A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes. PLoS Pathog. 2013  ;9(2):e1003168.

Gall A, Treuting P, Elkon KB, Loo Y-M, Gale M, Barber GN, Stetson DB. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity. 2012  ;36(1):120-31.

Pagán AJ, Pepper M, H Chu H, Green JM, Jenkins MK. CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs. J Immunol. 2012  ;189(6):2909-17.

Horner SM, Park HSoo, Gale M. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix ?0. J Virol. 2012  ;86(6):3112-20.

Petruzziello-Pellegrini TN, Yuen DA, Page AV, Patel S, Soltyk AM, Matouk CC, Wong DK, Turgeon PJ, Fish JE, Ho JJDavid, et al. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest. 2012  ;122(2):759-76.

Tobin DM, Roca FJ, Oh SF, McFarland R, Vickery TW, Ray JP, Ko DC, Zou Y, Bang ND, Chau TTH, et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell. 2012  ;148(3):434-46.

Shah JA, Vary JC, Chau TTH, Bang ND, Yen NTB, Farrar JJ, Dunstan SJ, Hawn TR. Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis. J Immunol. 2012  ;189(4):1737-46.

Ramos HJ, Lanteri MC, Blahnik G, Negash A, Suthar MS, Brassil MM, Sodhi K, Treuting PM, Busch MP, Norris PJ, et al. IL-1? signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 2012  ;8(11):e1003039.

Shen S, Fang FC. Integrated stress responses in Salmonella. Int J Food Microbiol. 2012  ;152(3):75-81.

Bedard KM, Wang ML, Proll SC, Loo Y-M, Katze MG, Gale M, Iadonato SP. Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses. J Virol. 2012  ;86(13):7334-44.

Crowther GJ, Quadri AS, Shannon-Alferes BJ, Van Voorhis WC, Rosen H. A mechanism-based whole-cell screening assay to identify inhibitors of protein export in Escherichia coli by the Sec pathway. J Biomol Screen. 2012  ;17(4):535-41.

Santos CC dos, Murthy S, Hu P, Shan Y, Haitsma JJ, Mei SHJ, Stewart DJ, W Liles C. Network analysis of transcriptional responses induced by mesenchymal stem cell treatment of experimental sepsis. Am J Pathol. 2012  ;181(5):1681-92.

Suthar MS, Ramos HJ, Brassil MM, Netland J, Chappell CP, Blahnik G, McMillan A, Diamond MS, Clark EA, Bevan MJ, et al. The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness. Immunity. 2012  ;37(2):235-48.

Smith RA, Raugi DN, Pan C, Coyne M, Hernandez A, Church B, Parker K, Mullins JI, Sow PSalif, Gottlieb GS. Three main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimens. PLoS One. 2012  ;7(9):e45372.

Lee H-C, Headley MB, Loo Y-M, Berlin A, Gale M, Debley JS, Lukacs NW, Ziegler SF. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol. 2012  ;130(5):1187-1196.e5.

West TE, Chierakul W, Chantratita N, Limmathurotsakul D, Wuthiekanun V, Emond MJ, Hawn TR, Peacock SJ, Skerrett SJ. Toll-like receptor 4 region genetic variants are associated with susceptibility to melioidosis. Genes Immun. 2012  ;13(1):38-46.

Schnell G, Loo Y-M, Marcotrigiano J, Gale M. Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I. PLoS Pathog. 2012  ;8(8):e1002839.

Doehle BP, Chang K, Fleming L, McNevin J, Hladik F, McElrath JM, Gale M. Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells. J Virol. 2012  ;86(16):8499-506.

Harman AN, Lai J, Turville S, Samarajiwa S, Gray L, Marsden V, Mercier SK, Mercier S, Jones K, Nasr N, et al. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood. 2011  ;118(2):298-308.

Loo Y-M, Gale M. Immune signaling by RIG-I-like receptors. Immunity. 2011  ;34(5):680-92.

Quakkelaar ED, Redeker A, Haddad EK, Harari A, McCaughey SM, Duhen T, Filali-Mouhim A, Goulet J-P, Loof NM, Ossendorp F, et al. Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS One. 2011  ;6(2):e16819.

Pepper M, Pagán AJ, Igyártó BZ, Taylor JJ, Jenkins MK. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity. 2011  ;35(4):583-95.

Ramos HJ, Gale M. RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr Opin Virol. 2011  ;1(3):167-76.

Liu HMinyi, Gale M. ZAPS electrifies RIG-I signaling. Nat Immunol. 2011  ;12(1):11-2.

Szretter KJ, Daffis S, Patel J, Suthar MS, Klein RS, Gale M, Diamond MS. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J Virol. 2010  ;84(23):12125-38.

Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, Rudensky AY, Bevan MJ, Clark EA, Kaja M-K, et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 2010  ;6(2):e1000757.

Gilchrist M, Henderson WR, Morotti A, Johnson CD, Nachman A, Schmitz F, Smith KD, Aderem A. A key role for ATF3 in regulating mast cell survival and mediator release. Blood. 2010  ;115(23):4734-41.

Chun CD, W Liles C, Frevert CW, Glenny RW, Altemeier WA. Mechanical ventilation modulates Toll-like receptor-3-induced lung inflammation via a MyD88-dependent, TLR4-independent pathway: a controlled animal study. BMC Pulm Med. 2010  ;10:57.

Wilkins C, Gale M. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol. 2010  ;22(1):41-7.

Shey MS, Randhawa AK, Bowmaker M, Smith E, Scriba TJ, de Kock M, Mahomed H, Hussey G, Hawn TR, Hanekom WA. Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin-6 secretion. Genes Immun. 2010  ;11(7):561-72.

Suthar MS, Gale M, Owen DM. Evasion and disruption of innate immune signalling by hepatitis C and West Nile viruses. Cell Microbiol. 2009  ;11(6):880-8.

Owen DM, Gale M. Fighting the flu with inflammasome signaling. Immunity. 2009  ;30(4):476-8.

Doehle BP, Hladik F, McNevin JP, McElrath JM, Gale M. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol. 2009  ;83(20):10395-405.

Horner SM, Gale M. Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. J Interferon Cytokine Res. 2009  ;29(9):489-98.

DeWitte-Orr SJ, Mehta DR, Collins SE, Suthar MS, Gale M, Mossman KL. Long double-stranded RNA induces an antiviral response independent of IFN regulatory factor 3, IFN-beta promoter stimulator 1, and IFN. J Immunol. 2009  ;183(10):6545-53.

Daffis S, Suthar MS, Gale M, Diamond MS. Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. J Innate Immun. 2009  ;1(5):435-45.

Serghides L, Patel SN, Ayi K, Lu Z, D Gowda C, W Liles C, Kain KC. Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria. J Infect Dis. 2009  ;199(10):1536-45.

T West E, Hawn TR, Skerrett SJ. Toll-like receptor signaling in airborne Burkholderia thailandensis infection. Infect Immun. 2009  ;77(12):5612-22.

Bollyky PL, Bice JB, Sweet IR, Falk BA, Gebe JA, Clark AE, Gersuk VH, Aderem A, Hawn TR, Nepom GT. The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury. PLoS One. 2009  ;4(4):e5063.

Gale M, Sen GC. Viral evasion of the interferon system. J Interferon Cytokine Res. 2009  ;29(9):475-6.

Loo Y-M, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, García-Sastre A, Katze MG, et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol. 2008  ;82(1):335-45.

Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol. 2008  ;82(2):609-16.

Charles JF, Humphrey MBeth, Zhao X, Quarles E, Nakamura MC, Aderem A, Seaman WE, Smith KD. The innate immune response to Salmonella enterica serovar Typhimurium by macrophages is dependent on TREM2-DAP12. Infect Immun. 2008  ;76(6):2439-47.

Saito T, Gale M. [RIG-I mediated hepatic innate immune signaling that controls HCV infection]. Uirusu. 2008  ;58(2):105-15.

E Misch A, Hawn TR. Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond). 2008  ;114(5):347-60.

Yeganeh M, Henneke P, Rezaei N, Ehl S, Thiel D, Matamoros N, Pietrogrande C, Espanol T, Litzman J, Franco JL, et al. Toll-like receptor stimulation induces higher TNF-alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndrome. Int Arch Allergy Immunol. 2008  ;146(3):190-4.

Clay H, Volkman HE, Ramakrishnan L. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity. 2008  ;29(2):283-94.

Altemeier WA, Zhu X, Berrington WR, Harlan JM, W Liles C. Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway. J Leukoc Biol. 2007  ;82(3):721-8.

Johnson CL, Owen DM, Gale M. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. J Biol Chem. 2007  ;282(14):10792-803.

Wagoner J, Austin M, Green J, Imaizumi T, Casola A, Brasier A, Khabar KSA, Wakita T, Gale M, Polyak SJ. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol. 2007  ;81(1):309-18.

Saito T, Hirai R, Loo Y-M, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A. 2007  ;104(2):582-7.

Malathi K, Dong B, Gale M, Silverman RH. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature. 2007  ;448(7155):816-9.

Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J, Hawn TR, Raines EW, Schwartz MW. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res. 2007  ;100(11):1589-96.

Johnson CL, Gale M. CARD games between virus and host get a new player. Trends Immunol. 2006  ;27(1):1-4.

Zhu X, Chang MSook, Hsueh RC, Taussig R, Smith KD, Simon MI, Choi S. Dual ligand stimulation of RAW 264.7 cells uncovers feedback mechanisms that regulate TLR-mediated gene expression. J Immunol. 2006  ;177(7):4299-310.

Cárdenas WB, Loo Y-M, Gale M, Hartman AL, Kimberlin CR, Martinez-Sobrido L, Saphire EOllmann, Basler CF. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol. 2006  ;80(11):5168-78.

Murphy SC, Harrison T, Hamm HE, Lomasney JW, Mohandas N, Haldar K. Erythrocyte G protein as a novel target for malarial chemotherapy. PLoS Med. 2006  ;3(12):e528.

Murphy SC, N Hiller L, Harrison T, Lomasney JW, Mohandas N, Haldar K. Lipid rafts and malaria parasite infection of erythrocytes. Mol Membr Biol. 2006  ;23(1):81-8.

Nhan TQ, W Liles C, Schwartz SM. Physiological functions of caspases beyond cell death. Am J Pathol. 2006  ;169(3):729-37.

Chien Y, Kim S, Bumeister R, Loo Y-M, Kwon SWon, Johnson CL, Balakireva MG, Romeo Y, Kopelovich L, Gale M, et al. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell. 2006  ;127(1):157-70.

Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, Gale M. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol. 2006  ;80(19):9424-34.

Turvey SE, Hawn TR. Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin Immunol. 2006  ;120(1):1-9.

Foy E, Li K, Sumpter R, Loo Y-M, Johnson CL, Wang C, Fish PMar, Yoneyama M, Fujita T, Lemon SM, et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A. 2005  ;102(8):2986-91.

Li K, Chen Z, Kato N, Gale M, Lemon SM. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem. 2005  ;280(17):16739-47.

Yaraei K, Campbell LAnn, Zhu X, W Liles C, Kuo C-C, Rosenfeld ME. Effect of Chlamydia pneumoniae on cellular ATP content in mouse macrophages: role of Toll-like receptor 2. Infect Immun. 2005  ;73(7):4323-6.

Gale M, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature. 2005  ;436(7053):939-45.

Hawn TR, Ozinsky A, Williams LM, Rodrigues S, Clark A, Pham U, Hill HR, Ochs H, Aderem A, W Liles C. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes. Hum Immunol. 2005  ;66(7):842-7.

Li K, Foy E, Ferreon JC, Nakamura M, Ferreon ACM, Ikeda M, Ray SC, Gale M, Lemon SM. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A. 2005  ;102(8):2992-7.

Martin TR, Frevert CW. Innate immunity in the lungs. Proc Am Thorac Soc. 2005  ;2(5):403-11.

Sumpter R, Loo Y-M, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol. 2005  ;79(5):2689-99.

Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo Y-M, Gale M, Akira S, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol. 2005  ;175(5):2851-8.

Fang FC. Sigma cascades in prokaryotic regulatory networks. Proc Natl Acad Sci U S A. 2005  ;102(14):4933-4.

Ogushi K-ichi, Wada A, Niidome T, Okuda T, Llanes R, Nakayama M, Nishi Y, Kurazono H, Smith KD, Aderem A, et al. Gangliosides act as co-receptors for Salmonella enteritidis FliC and promote FliC induction of human beta-defensin-2 expression in Caco-2 cells. J Biol Chem. 2004  ;279(13):12213-9.

Pozos TC, Ramakrishnan L, Ramakrishan L. New models for the study of Mycobacterium-host interactions. Curr Opin Immunol. 2004  ;16(4):499-505.

Aderem A, Smith KD. A systems approach to dissecting immunity and inflammation. Semin Immunol. 2004  ;16(1):55-67.

Vazquez-Torres A, Vallance BA, Bergman MA, B Finlay B, Cookson BT, Jones-Carson J, Fang FC. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol. 2004  ;172(10):6202-8.

Hawn TR, Verbon A, Lettinga KD, Zhao LPing, Li SSue, Laws RJ, Skerrett SJ, Beutler B, Schroeder L, Nachman A, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med. 2003  ;198(10):1563-72.

Bochud P-Y, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol. 2003  ;170(7):3451-4.

Marr KA, S Balajee A, Hawn TR, Ozinsky A, Pham U, Akira S, Aderem A, W Liles C. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun. 2003  ;71(9):5280-6.

Schaub FJ, W Liles C, Ferri N, Sayson K, Seifert RA, Bowen-Pope DF. Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1alpha. Circ Res. 2003  ;93(6):515-22.

Park DR, Thomsen AR, Frevert CW, Pham U, Skerrett SJ, Kiener PA, W Liles C. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol. 2003  ;170(12):6209-16.

Picard C, Puel A, Bonnet M, Ku C-L, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 2003  ;299(5615):2076-9.

Bader MW, Navarre WWiley, Shiau W, Nikaido H, Frye JG, McClelland M, Fang FC, Miller SI. Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol. 2003  ;50(1):219-30.

Hawn TR, Ozinsky A, Underhill DM, Buckner FS, Akira S, Aderem A. Leishmania major activates IL-1 alpha expression in macrophages through a MyD88-dependent pathway. Microbes Infect. 2002  ;4(8):763-71.

Stamler JS, Lamas S, Fang FC. Nitrosylation. the prototypic redox-based signaling mechanism. Cell. 2001  ;106(6):675-83.

Xie H, Cook GS, Costerton JW, Bruce G, Rose TM, Lamont RJ. Intergeneric communication in dental plaque biofilms. J Bacteriol. 2000  ;182(24):7067-9.

Imanishi T, Hano T, Nishio I, Liles WC, Schwartz SM, Han DK. Transition of apoptotic resistant vascular smooth muscle cells to troptotic sensitive state is correlated with downregulation of c-FLIP. J Vasc Res. 2000  ;37(6):523-31.

Broudy VC, Lin NL, Liles WC, Corey SJ, O'Laughlin B, Mou S, Linnekin D. Signaling via Src family kinases is required for normal internalization of the receptor c-Kit. Blood. 1999  ;94(6):1979-86.

Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med. 1996  ;184(2):429-40.

Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ. Cross-linking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli: implications for adhesion-dependent physiological responses in neutrophils. J Leukoc Biol. 1995  ;58(6):690-7.

Liles WC, Klebanoff SJ. Regulation of apoptosis in neutrophils--Fas track to death?. J Immunol. 1995  ;155(7):3289-91.

Bruce AG, Linsley PS, Rose TM. Oncostatin M. Prog Growth Factor Res. 1992  ;4(2):157-70.